M
It finally happened.
According to the FDA, there is no longer a shortage of semaglutide, the active ingredient in the wildly popular Ozempic and Wegovy — a very bad omen for the countless telehealth and pharmacy businesses selling “compounded” versions of the diabetes and weight-loss drug. The FDA has clarified that state-licensed and out-sourcing operations have to cease production of the “compounded” medication by April 22nd and May 22nd, respectively.
The Ozempic Shortage Is Over
[wired.com]
Follow topics and authors from this story to see more like this in your personalized homepage feed and to receive email updates.
Loading comments
Getting the conversation ready...
Most Popular
Most Popular
- Midjourney goes from generating cat images to full-body ultrasound scans
- Apple’s weird anti-nausea dots cured my car sickness
- Tim Cook says RAM expenses are ‘unsustainable’ and Apple is going to raise prices
- This Ghost in the Shell keyboard makes me want to activate the hundred spidery robot fingers inside my regular fingers
- Amazon employees say they’re facing termination for backing data center limits
